Loading clinical trials...
Loading clinical trials...
The primary objective of this trial is to determine whether treatment with tiotropium (18 mcg) capsule once daily via the HandiHaler reduces the proportion of patients with COPD experiencing an exacer...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Boehringer Ingelheim
NCT06712563 · Pulmonary Disease, Chronic Obstructive
NCT07518472 · Pulmonary Disease, Chronic Obstructive (COPD)
NCT06831994 · Asthma Bronchiale, Breast Neoplasms, and more
NCT05730088 · Pulmonary Disease, Chronic Obstructive
NCT02755974 · Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim Investigational Site
Birmingham, Alabama
Carl T. Hayden VA Medical Center
Phoenix, Arizona
Southern Arizona VA Health Care System
Tuscon, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions